SAN JOSE, Calif., July 14, 2025 (GLOBE NEWSWIRE) -- Rani Therapeutics Holdings, Inc. (“Rani Therapeutics” or “Rani”) (Nasdaq: RANI), a clinical-stage biotherapeutics company focused on the oral delivery of biologics and drugs, today announced that it will present preclinical data on the RaniPill® capsule at the Endocrine Society’s Annual Meeting (ENDO 2025) taking place July 12-15 in San Francisco, CA.
Anavar for Women is trending in 2025 as fitness-focused women seek safer, effective cutting support. Discover how Anvarol is emerging as a leading legal alternative tailored for lean muscle tone, stamina, and strength—without synthetic risk.
Anavar for Women is trending in 2025 as fitness-focused women seek safer, effective cutting support. Discover how Anvarol is emerging as a leading legal alternative tailored for lean muscle tone, stamina, and strength—without synthetic risk.
Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Hims & Hers (HIMS), Sarepta (SRPT), or PetCo (WOOF) To Contact Him Directly To Discuss Their Options
Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Vestis (VSTS), PepGen (PEPG), Reckitt (RBGLY), or Tempus (TEM) To Contact Him Directly To Discuss Their Options
Helping providers understand compounding to deliver more personalized patient care.
GILBERT, Ariz., July 11, 2025 /PRNewswire/ -- Strive Compounding Pharmacy, a leader in personalized healthcare...
Industry leader with nearly 50 years serving drivers supports marketplace solving critical truck parking shortage
CHATTANOOGA, Tenn. and WALCOTT, Iowa, July 11, 2025 /PRNewswire/ --...
BIEL, Switzerland and BERN, Switzerland, July 11, 2025 /PRNewswire/ -- As product requirements evolve, engineers and designers search for solutions that enable greater integration,...